{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:08:06Z","timestamp":1761523686454},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s00105-013-2696-9","type":"journal-article","created":{"date-parts":[[2014,5,12]],"date-time":"2014-05-12T11:42:51Z","timestamp":1399894971000},"page":"397-408","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Kutane Arzneimittelreaktionen vom Sp\u00e4ttyp","Delayed-type cutaneous drug reactions"],"prefix":"10.1007","volume":"65","author":[{"given":"M.","family":"Ziemer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,11]]},"reference":[{"key":"2696_CR1","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","volume":"356","author":"Edwards","year":"2000","unstructured":"Edwards IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis, and management. Lancet 356(9237):1255\u20131259","journal-title":"Lancet"},{"key":"2696_CR2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.pharmtox.47.120505.105150","volume":"47","author":"Uetrecht","year":"2007","unstructured":"Uetrecht J (2007) Idiosyncratic drug reactions: current understanding. Annu Rev Pharmacol Toxicol 47:513\u2013539","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2696_CR3","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jaci.2003.12.591","volume":"113","author":"Johansson","year":"2004","unstructured":"Johansson SG, Bieber T, Dahl R et al (2004) Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 113:832\u2013836","journal-title":"J Allergy Clin Immunol"},{"key":"2696_CR4","doi-asserted-by":"crossref","first-page":"683","DOI":"10.7326\/0003-4819-139-8-200310210-00012","volume":"139","author":"Pichler","year":"2003","unstructured":"Pichler WJ (2003) Delayed drug hypersensitivity reactions. Ann Intern Med 139:683\u2013693","journal-title":"Ann Intern Med"},{"key":"2696_CR5","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1067\/mai.2000.110922","volume":"106","author":"Yawalkar","year":"2000","unstructured":"Yawalkar N, Shrikhande M, Hari Y et al (2000) Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions. J Allergy Clin Immunol 106:1171\u20131176","journal-title":"J Allergy Clin Immunol"},{"key":"2696_CR6","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1034\/j.1398-9995.2000.00628.x","volume":"55","author":"Blanca","year":"2000","unstructured":"Blanca M, Posadas S, Torres MJ et al (2000) Expression of the skin-homing receptor in peripheral blood lymphocytes from subjects with nonimmediate cutaneous allergic drug reactions. Allergy 55:998\u20131004","journal-title":"Allergy"},{"key":"2696_CR7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1517\/14740338.6.2.109","volume":"6","author":"Naisbitt","year":"2007","unstructured":"Naisbitt DJ, Pirmohamed M, Park BK (2007) Immunological principles of T-cell-mediated adverse drug reactions in skin. Expert Opin Drug Saf 6:109\u2013124","journal-title":"Expert Opin Drug Saf"},{"key":"2696_CR8","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.coi.2009.09.009","volume":"21","author":"Metz","year":"2009","unstructured":"Metz M, Maurer M (2009) Innate immunity and allergy in the skin. Curr Opin Immunol 21:687\u2013693","journal-title":"Curr Opin Immunol"},{"key":"2696_CR9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-3-540-71029-5_7","volume":"188","author":"Ramirez-Gonzalez","year":"2009","unstructured":"Ramirez-Gonzalez MD, Herrera-Enriquez M, Villanueva-Rodriguez LG et al (2009) Role of epidermal dendritic cells in drug-induced cutaneous adverse reactions. Handb Exp Pharmacol 188:137\u2013162","journal-title":"Handb Exp Pharmacol"},{"key":"2696_CR10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/QCO.0b013e3283298e62","volume":"22","author":"Fernandez","year":"2009","unstructured":"Fernandez TD, Canto G, Blanca M (2009) Molecular mechanisms of maculopapular exanthema. Curr Opin Infect Dis 22:272\u2013278","journal-title":"Curr Opin Infect Dis"},{"key":"2696_CR11","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.jaci.2010.11.047","volume":"127","author":"Romano","year":"2011","unstructured":"Romano A, Torres MJ, Castells M et al (2011) Diagnosis and management of drug hypersensitivity reactions. J Allergy Clin Immunol 127(3 Suppl):S67\u2013S73","journal-title":"J Allergy Clin Immunol"},{"key":"2696_CR12","first-page":"104","volume":"5","author":"Williams","year":"2002","unstructured":"Williams DP, Naisbitt DJ (2002) Toxicophores: groups and metabolic routes associated with increased safety risk. Curr Opin Drug Discov Devel 5:104\u2013115","journal-title":"Curr Opin Drug Discov Devel"},{"key":"2696_CR13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1523-1747.2001.01298.x","volume":"116","author":"Baron","year":"2001","unstructured":"Baron JM, Holler D, Schiffer R et al (2001) Expression of multiple cytochrome p450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes. J Invest Dermatol 116:541\u2013548","journal-title":"J Invest Dermatol"},{"key":"2696_CR14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000057751","volume":"127","author":"Saeki","year":"2002","unstructured":"Saeki M, Saito Y, Nagano M et al (2002) mRNA expression of multiple cytochrome p450 isozymes in four types of cultured skin cells. Int Arch Allergy Immunol 127:333\u2013336","journal-title":"Int Arch Allergy Immunol"},{"key":"2696_CR15","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/03602530600959615","volume":"38","author":"Uetrecht","year":"2006","unstructured":"Uetrecht J (2006) Evaluation of which reactive metabolite, if any, is responsible for a specific idiosyncratic reaction. Drug Metab Rev 38:745\u2013753","journal-title":"Drug Metab Rev"},{"key":"2696_CR16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.tox.2004.12.019","volume":"209","author":"Uetrecht","year":"2005","unstructured":"Uetrecht J (2005) Role of drug metabolism for breaking tolerance and the localization of drug hypersensitivity. Toxicology 209:113\u2013118","journal-title":"Toxicology"},{"key":"2696_CR17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/archderm.140.2.183","volume":"140","author":"Kano","year":"2004","unstructured":"Kano Y, Inaoka M, Shiohara T (2004) Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia. Arch Dermatol 140:183\u2013188","journal-title":"Arch Dermatol"},{"key":"2696_CR18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1001\/archderm.1981.01650030018010","volume":"117","author":"Seehafer","year":"1981","unstructured":"Seehafer JR, Rogers RS III, Fleming CR et al (1981) Lichen planus-like lesions caused by penicillamine in primary biliary cirrhosis. Arch Dermatol 117:140\u2013142","journal-title":"Arch Dermatol"},{"key":"2696_CR19","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1365-2133.1967.tb11539.x","volume":"79","author":"Anderson","year":"1967","unstructured":"Anderson TE (1967) Lichen planus following quinidine therapy. Br J Dermatol 79:500","journal-title":"Br J Dermatol"},{"key":"2696_CR20","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.autrev.2004.11.005","volume":"4","author":"Shiohara","year":"2005","unstructured":"Shiohara T, Mizukawa Y (2005) The immunological basis of lichenoid tissue reaction. Autoimmun Rev 4:236\u2013241","journal-title":"Autoimmun Rev"},{"key":"2696_CR21","first-page":"278","volume":"2","author":"Nigen","year":"2003","unstructured":"Nigen S, Knowles SR, Shear NH (2003) Drug eruptions: approaching the diagnosis of drug-induced skin diseases. J Drugs Dermatol 2:278\u2013299","journal-title":"J Drugs Dermatol"},{"key":"2696_CR22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jdermsci.2004.12.002","volume":"38","author":"Park","year":"2005","unstructured":"Park HJ, Kim HS, Kim HJ et al (2005) Immunohistochemical characterization of cutaneous drug eruptions by STI571. J Dermatol Sci 38:9\u201315","journal-title":"J Dermatol Sci"},{"key":"2696_CR23","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1001\/archderm.134.8.1040","volume":"134","author":"Barbaud","year":"1998","unstructured":"Barbaud AM, Bene MC, Reichert-Penetrat S et al (1998) Immunocompetent cells and adhesion molecules in 14 cases of cutaneous drug reactions induced with the use of antibiotics. Arch Dermatol 134:1040\u20131041","journal-title":"Arch Dermatol"},{"key":"2696_CR24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/ACI.0b013e32832d565c","volume":"9","author":"Rozieres","year":"2009","unstructured":"Rozieres A, Vocanson M, Said BB et al (2009) Role of T cells in nonimmediate allergic drug reactions. Curr Opin Allergy Clin Immunol 9:305\u2013310","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"2696_CR25","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1398-9995.2008.01674.x","volume":"64","author":"Rozieres","year":"2009","unstructured":"Rozieres A, Hennino A, Rodet K et al (2009) Detection and quantification of drug-specific T cells in penicillin allergy. Allergy 64:534\u2013542","journal-title":"Allergy"},{"key":"2696_CR26","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1046\/j.1365-2222.2000.00847.x","volume":"30","author":"Yawalkar","year":"2000","unstructured":"Yawalkar N, Egli F, Hari Y et al (2000) Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions. Clin Exp Allergy 30:847\u2013855","journal-title":"Clin Exp Allergy"},{"key":"2696_CR27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2165\/00128071-200203040-00001","volume":"3","author":"Pichler","year":"2002","unstructured":"Pichler WJ, Yawalkar N, Britschgi M et al (2002) Cellular and molecular pathophysiology of cutaneous drug reactions. Am J Clin Dermatol 3:229\u2013238","journal-title":"Am J Clin Dermatol"},{"key":"2696_CR28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/DER.0b013e3182a0d38a","volume":"24","author":"Aquino","year":"2013","unstructured":"Aquino MR, Sher J, Fonacier L (2013) Patch testing for drugs. Dermatitis 24(5):205\u2013214","journal-title":"Dermatitis"},{"key":"2696_CR29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1034\/j.1600-0536.2001.450601.x","volume":"45","author":"Barbaud","year":"2001","unstructured":"Barbaud A, Goncalo M, Bruynzeel D et al (2001) Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermat 45:321\u2013328","journal-title":"Contact Dermat"},{"key":"2696_CR30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.0105-4538.2001.00001.x-i8","volume":"57","author":"Brockow","year":"2002","unstructured":"Brockow K, Romano A, Blanca M et al (2002) General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 57:45\u201351","journal-title":"Allergy"},{"key":"2696_CR31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.tox.2004.12.024","volume":"209","author":"Barbaud","year":"2005","unstructured":"Barbaud A (2005) Drug patch testing in systemic cutaneous drug allergy. Toxicology 209:209\u2013216","journal-title":"Toxicology"},{"key":"2696_CR32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0190-9622(93)70176-T","volume":"29","author":"Halevy","year":"1993","unstructured":"Halevy S, Shai A (1993) Lichenoid drug eruptions. J Am Acad Dermatol 29(2 Pt 1):249\u2013255","journal-title":"J Am Acad Dermatol"},{"key":"2696_CR33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000075054","volume":"208","author":"Teraki","year":"2004","unstructured":"Teraki Y, Shiohara T (2004) Spontaneous tolerance to terbinafine-induced lichenoid drug eruption. Dermatology 208:81\u201382","journal-title":"Dermatology"},{"key":"2696_CR34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5070\/D335C1029X","volume":"15","author":"Brauer","year":"2009","unstructured":"Brauer J, Votava HJ, Meehan S et al (2009) Lichenoid drug eruption. Dermatol Online J 15:13","journal-title":"Dermatol Online J"},{"key":"2696_CR35","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/jid.2009.42","volume":"129","author":"Sontheimer","year":"2009","unstructured":"Sontheimer RD (2009) Lichenoid tissue reaction\/interface dermatitis: clinical and histological perspectives. J Invest Dermatol 129:1088\u20131099","journal-title":"J Invest Dermatol"},{"key":"2696_CR36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000248091","volume":"179","author":"Van","year":"1989","unstructured":"Van den Haute V, Antoine JL, Lachapelle JM (1989) Histopathological discriminant criteria between lichenoid drug eruption and idiopathic lichen planus: retrospective study on selected samples. Dermatologica 179:10\u201313","journal-title":"Dermatologica"},{"key":"2696_CR37","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/j.1875-9114.1994.tb02852.x","volume":"14","author":"Thompson","year":"1994","unstructured":"Thompson DF, Skaehill PA (1994) Drug-induced lichen planus. Pharmacotherapy 14:561\u2013571","journal-title":"Pharmacotherapy"},{"key":"2696_CR38","unstructured":"Bork K (1988) Lichenoid eruptions. In: Bork K (Hrsg) Cutaneous side effects of drugs. Saunders, Philadephia, S\u00a0170"},{"key":"2696_CR39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/jid.1947.92","volume":"9","author":"Sulzberger","year":"1947","unstructured":"Sulzberger MB, Herrmann F, Zak FG (1947) Studies of sweating; preliminary report with particular emphasis of a sweat retention syndrome. J Invest Dermatol 9:221\u2013242","journal-title":"J Invest Dermatol"},{"key":"2696_CR40","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00130832-200108000-00004","volume":"1","author":"Yawalkar","year":"2001","unstructured":"Yawalkar N, Pichler WJ (2001) Immunohistology of drug-induced exanthema: clues to pathogenesis. Curr Opin Allergy Clin Immunol 1:299\u2013303","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"2696_CR41","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1365-2133.2000.03355.x","volume":"142","author":"Sugerman","year":"2000","unstructured":"Sugerman PB, Satterwhite K, Bigby M (2000) Autocytotoxic T-cell clones in lichen planus. Br J Dermatol 142:449\u2013456","journal-title":"Br J Dermatol"},{"key":"2696_CR42","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1046\/j.1439-0353.2004.04524.x","volume":"2","author":"Yawalkar","year":"2004","unstructured":"Yawalkar N, Pichler WJ (2004) Mechanisms of cutaneous drug reactions. J Dtsch Dermatol Ges 2:1013\u20131023 (quiz 1024\u20131026)","journal-title":"J Dtsch Dermatol Ges"},{"key":"2696_CR43","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/jid.2008.251","volume":"129","author":"Meller","year":"2009","unstructured":"Meller S, Gilliet M, Homey B (2009) Chemokines in the pathogenesis of lichenoid tissue reactions. J Invest Dermatol 129:315\u2013319","journal-title":"J Invest Dermatol"},{"key":"2696_CR44","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1600-0560.2006.00527.x","volume":"33","author":"Wenzel","year":"2006","unstructured":"Wenzel J, Scheler M, Proelss J et al (2006) Type I interferon-associated cytotoxic inflammation in lichen planus. J Cutan Pathol 33:672\u2013678","journal-title":"J Cutan Pathol"},{"key":"2696_CR45","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000074116","volume":"207","author":"Erdem","year":"2003","unstructured":"Erdem MT, Gulec AI, Kiziltunc A et al (2003) Increased serum levels of tumor necrosis factor alpha in lichen planus. Dermatology 207:367\u2013370","journal-title":"Dermatology"},{"key":"2696_CR46","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00000372-199306000-00004","volume":"15","author":"Akasu","year":"1993","unstructured":"Akasu R, From L, Kahn HJ (1993) Lymphocyte and macrophage subsets in active and inactive lesions of lichen planus. Am J Dermatopathol 15(3):217\u2013223","journal-title":"Am J Dermatopathol"},{"key":"2696_CR47","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1365-2133.1971.tb14100.x","volume":"85","author":"Almeyda","year":"1971","unstructured":"Almeyda J, Levantine A (1971) Drug reactions. XVI. Lichenoid drug eruptions. Br J Dermatol 85:604\u2013607","journal-title":"Br J Dermatol"},{"key":"2696_CR48","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/archderm.1940.01490180114009","volume":"42","author":"Wile","year":"1940","unstructured":"Wile UJ, Courville CJ (1940) Pityriasis-rosea-like dermatitis following gold therapy report of two cases. Arch Dermatol Syph 42:1105\u20131112","journal-title":"Arch Dermatol Syph"},{"key":"2696_CR49","first-page":"334","volume":"63","author":"Cairns","year":"1951","unstructured":"Cairns RJ (1951) Lichenoid gold eruption. Br J Dermatol 63:334\u2013335","journal-title":"Br J Dermatol"},{"key":"2696_CR50","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.7326\/0003-4819-31-6-1078","volume":"31","author":"Feder","year":"1949","unstructured":"Feder A (1949) Clinical observations on atypical lichen planus and related dermatoses presumably due to atabrine toxicity. Ann Intern Med 31:1078\u20131089 (illust)","journal-title":"Ann Intern Med"},{"key":"2696_CR51","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2133.1958.tb13315.x","volume":"70","author":"Savage","year":"1958","unstructured":"Savage J (1958) Lichenoid dermatitis due to chloroquine. Br J Dermatol 70:181","journal-title":"Br J Dermatol"},{"key":"2696_CR52","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/bmj.320.7230.283","volume":"320","author":"Bong","year":"2000","unstructured":"Bong JL, Lucke TW, Douglas WS (2000) Lichenoid drug eruption with proton pump inhibitors. BMJ 320(7230):283","journal-title":"BMJ"},{"key":"2696_CR53","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/j.1346-8138.2005.tb00884.x","volume":"32","author":"Antiga","year":"2005","unstructured":"Antiga E, Melani L, Cardinali C et al (2005) A case of lichenoid drug eruption associated with sildenafil citratus. J Dermatol 32:972\u2013975","journal-title":"J Dermatol"},{"key":"2696_CR54","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaad.2008.09.032","volume":"61","author":"Asarch","year":"2009","unstructured":"Asarch A, Gottlieb AB, Lee J et al (2009) Lichen planus-like eruptions: an emerging side effect of tumor necrosis factor-alpha antagonists. J Am Acad Dermatol 61:104\u2013111","journal-title":"J Am Acad Dermatol"},{"key":"2696_CR55","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1468-3083.2007.02558.x","volume":"22","author":"De","year":"2008","unstructured":"De Simone C, Caldarola G, D\u2019Agostino M et al (2008) Lichenoid reaction induced by adalimumab. J Eur Acad Dermatol Venereol 22:626\u2013627","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2696_CR56","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/j.1365-2133.2008.08529.x","volume":"158","author":"Garcovich","year":"2008","unstructured":"Garcovich S, Manco S, Zampetti A et al (2008) Onset of lichen planopilaris during treatment with etanercept. Br J Dermatol 158:1161\u20131163","journal-title":"Br J Dermatol"},{"key":"2696_CR57","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1001\/archderm.138.9.1258","volume":"138","author":"Vergara","year":"2002","unstructured":"Vergara G, Silvestre JF, Betlloch I et al (2002) Cutaneous drug eruption to infliximab: report of 4 cases with an interface dermatitis pattern. Arch Dermatol 138:1258\u20131259","journal-title":"Arch Dermatol"},{"key":"2696_CR58","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0190-9622(89)70174-2","volume":"21","author":"Oliver","year":"1989","unstructured":"Oliver GF, Winkelmann RK, Muller SA (1989) Lichenoid dermatitis: a clinicopathologic and immunopathologic review of sixty-two cases. J Am Acad Dermatol 21(2 Pt 1):284\u2013292","journal-title":"J Am Acad Dermatol"},{"key":"2696_CR59","first-page":"210","volume":"9","author":"Klaschka","year":"1990","unstructured":"Klaschka F, Ring J (1990) Systemically induced (hematogenous) contact eczema. Semin Dermatol 9:210\u2013215","journal-title":"Semin Dermatol"},{"key":"2696_CR60","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s00105-005-1079-2","volume":"57","author":"Erdmann","year":"2006","unstructured":"Erdmann SM, Werfel T (2006) Hematogenous contact eczema induced by foods. Hautarzt 57:116\u2013120","journal-title":"Hautarzt"},{"key":"2696_CR61","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.0105-1873.2004.00445.x","volume":"51","author":"Hausermann","year":"2004","unstructured":"Hausermann P, Harr T, Bircher AJ (2004) Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome? Contact Dermat 51:297\u2013310","journal-title":"Contact Dermat"},{"key":"2696_CR62","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/ACI.0b013e3283489d5f","volume":"11","author":"Tan","year":"2011","unstructured":"Tan SC, Tan JW (2011) Symmetrical drug-related intertriginous and flexural exanthema. Curr Opin Allergy Clin Immunol 11:313\u2013318","journal-title":"Curr Opin Allergy Clin Immunol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-013-2696-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-013-2696-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-013-2696-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T16:10:32Z","timestamp":1716739832000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-013-2696-9"}},"subtitle":["Pathogenese, Klinik und Histologie","Pathogenesis, clinical features and histology"],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["2696"],"URL":"https:\/\/doi.org\/10.1007\/s00105-013-2696-9","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}